Lazard Asset Management »

Enzo Biochem shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Enzo Biochem (ENZ) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Enzo Biochem

Tip: Access up to 7 years of quarterly data

All positions including Enzo Biochem held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enzo Biochem by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $54k 51k 1.07
2023-12-31 $70k 51k 1.39
2023-09-30 $70k 51k 1.39
2023-06-30 $92k 51k 1.82
2023-03-31 $122k 51k 2.42

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Alphabet Inc A Common Stock (GOOGL)
Apple Common Stock (AAPL)
Visa Common Stock (V)
Norfolk Souther Common Stock (NSC)
Intercontinen Common Stock (ICE)
Unitedhealth Gr Common Stock (UNH)
Accenture Common Stock (ACN)
Applied Matls I Common Stock (AMAT)
Bank Of America Common Stock (BAC)
Nvidia Corp Common Stock (NVDA)
Broadcom Common Stock (AVGO)
Thermo Fisher Common Stock (TMO)
Aon Plc/ireland Common Stock (AON)

View all positions for Lazard Asset Management

Top funds holding Enzo Biochem

Harbert Fund Advisors
Renaissance Technologies
Vanguard Group
BlackRock
Geode Capital Management
Dimensional Fund Advisors
Rbf Capital
State Street Corporation
Bridgeway Capital Management
Nierenberg Investment Management Company
Morgan Stanley
Wittenberg Investment Management
Northern Trust
Lazard Asset Management
T. Rowe Price Associates

View all funds holding Enzo Biochem